Nice break down good logical thinking but Charlie Sheen would argue with you on mono. Time will tell. I say if they figure out the biomarkers which with 300 they have a good chance and figuring out the right dosage for ccr5. I don't think that's a dream I think that is possible. This drug is outside the box. It's a winner anyway you slice it up Adjacent or both
Wow, a low end of $5 or $4 if there were more dilution ? A $2B b.o. is a middle figure, I gather from your post. But that is not including mono; ok. I find patience harder to hold on to.